This document discusses buccal drug delivery systems (BDDS), which deliver drugs through the buccal mucosa in the mouth. It notes that BDDS avoids first-pass metabolism, offers a large surface area and good patient compliance compared to other routes. Various BDDS formats are described, including buccal tablets, patches, films and hydrogels. Key factors like mucus, bioadhesion and drug release kinetics are also summarized. Evaluation tests for BDDS include thickness measurements, swelling study, surface pH, weight uniformity and in vitro drug release.